BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2013
View Archived Issues
Merck KGaA announces new partnerships with Israeli companies
Read More
Inhibition of PDE10 shows promise in lung orthotopic mouse model
Read More
Design of the first animal model of spontaneous atherothrombotic occlusion due to plaque erosion
Read More
Results reported from phase I study of a double-mutant enterotoxin for traveler's diarrhea
Read More
Cognition Therapeutics' Abeta oligomer receptor antagonists for Alzheimer's disease
Read More
Report on development of peptides for inhibiting Abeta aggregation in Alzheimer's disease
Read More
Lycera Corp. presents new ROR-gamma agonists
Read More
Merck & Co. synthesizes novel alpha-type CGRP receptor antagonists
Read More
DBPR-211 as a potent and orally active CB1 antagonist in vivo
Read More
Novel MetAP 2 inhibitors patented by Zalgen for obesity
Read More
Piramal Enterprises presents novel agents for cancer
Read More
BPR-000A leads to reductions in tumor size in vivo
Read More
Pfizer to begin phase I study of PF-06263276 in healthy subjects
Read More
Japanese researchers invent novel MCH-R1 antagonists for obesity
Read More
Genentech enrolls patients in phase II trial of MHAA-4549-A
Read More
Alchemia provides update on phase III HA-irinotecan trial
Read More
Ferrer and Janus Developments create new strategic alliance
Read More
Daiichi Sankyo launches new formulation of natural tetrahydrobiopterin agent
Read More
GlaxoSmithKline receives positive CHMP opinion for two-dose schedule of Cervarix
Read More
Collaboration to generate new cancer drugs in the field of epigenetics
Read More
Navidea to collaborate with UAB on study of RIGS monoclonal antibody targeting agent
Read More
Sareum signs codevelopment agreement with HMUBEC
Read More
InnaVirVax initiates phase II study of VAC-3S with ART in HIV-1
Read More
Cell Therapeutics receives sales milestone payment for Trisenox
Read More
PNP Therapeutics advances phase I trial in head and neck cancer
Read More
